STK11 and breast cancer: Our previous studies have demonstrated that oral ranitidine treatment can reduce solid tumor growth in the E0771-GFP model, inhibit tumor metastasis in the 4T1 model, and limit the development of tumors in a targeted Lkb1-deficient breast cancer model (10).